Journal of Investigative Medicine

作者身份政策指出,作者身份标准、谁应担任通讯作者等信息请查看作者身份政策;AI聊天机器人(例如ChatGPT)不应被列为作者,详见关于使用ChatGPT和生成式AI工具的政策。 模型中文摘要

Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

数据可用性政策指出,期刊致力于促进研究的开放、透明和可重复性,并实行研究数据共享政策;在符合伦理和法律考虑的前提下,鼓励作者将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明,若无法共享数据则用声明说明原因,并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

伦理政策指出,即使已在方法部分包含伦理批准信息,也请在伦理标题下包含伦理批准声明;若无需伦理批准,须明确说明;所有报告涉及人类参与者、人类数据或人体组织的研究的论文,必须声明相关伦理委员会或机构审查委员会批准了研究或豁免了批准要求,并提供审查委员会的全称和机构以及批准号;如适用,也请在方法部分包含此信息。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

开放获取政策指出,向本期刊投稿或发表无需支付任何费用;可选的开放获取发表可通过Sage Choice计划(收费)和开放获取协议进行,作者可根据与Sage的协议以折扣价或免费发表开放获取文章;开放获取协议资格由通讯作者的机构在录用时匹配到协议决定。 模型中文摘要

There are no fees payable to submit or publish in this journal. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement …

同行评审政策指出,本期刊实行单盲身份透明(评审人与编辑互动,不公布评审信息);稿件先经初步评估,不符合指南要求的稿件将在同行评审前退回修改,超出期刊范围或不适用的稿件可能在此阶段被直接拒稿;通过初步评估后,稿件将进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

剽窃政策指出,期刊和Sage非常重视版权侵权、剽窃或其他违反出版最佳实践的问题,请阅读Sage关于剽窃的完整政策及可能采取的行动。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

预印本政策指出,期刊将考虑已在预印本服务器上发布的稿件;投稿时请在指定字段输入预印本DOI,并建议在投稿时告知期刊编辑部已发布的预印本;同行评审期间不应在预印本服务器上发布稿件的更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

临床试验注册政策指出,期刊遵循ICMJE要求,临床试验须在首次招募参与者时或之前在WHO批准的公共试验注册机构注册,作为考虑发表的条件;试验注册机构名称和URL以及注册号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.